NCT01445613View on ClinicalTrials.gov

Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy

NACompletedINTERVENTIONAL
Enrollment

1,203

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2016

Conditions
Carotid Artery DiseaseStrokeAmaurosis FugaxTransient Ischemic Attack (TIA)
Interventions
DEVICE

RX Acculink Carotid Stent System (RX Acculink)

Those patients receiving the RX Acculink used with an Embolic Protection System (EPS) approved for use with RX Acculink.

Trial Locations (1)

95054

Abbott Vascular, Santa Clara

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY